Bioverge Portfolio
-
Personalized microbiome health services & data platform
Seed
- $2.5M annualized revenue
- Clinical-grade data and quality control
- Strategic investment by Unilever, Walton Family
Offered By: Bioverge Funds Management LLC
Revolutionizing Preclinical Drug Discovery
Seed
- $21 billion market opportunity
- Saas model w/ 2019 rev. of $272K
- >30 paying customers, including global pharma
Offered By: Bioverge Funds Management LLC
The Bioverge platform is host to both Regulation Crowdfunding and Regulation D offering types. Reg CF offerings are provided by Bioverge Portal LLC and Reg D offering are provided by Bioverge Funds Management LLC. Companies designated as BV Showcase are enrolled in a program managed by Bioverge Inc and are not associated with an offering on the Bioverge platform.
The Bioverge Pulse
In the News...
Become a Bioverge Pro!
Reduce your carry
Gain early access
See exclusive deals
Obtain early liquidity
Reimagine Retirement Investing
Alto delivers a fast, hassle-free process for investing your IRA savings with Bioverge
